Auron Therapeutics

Recent Finacing

Series A

Recent Raise

$48M

Auron Therapeutics develops cancer differentiation therapies that reactivate endogenous programs to induce tumor cell maturation, using a multi-omic AURigin platform to identify targets, agents and biomarkers for clinical development.

Founded 2018

Massachusetts, United States

1-10

Private

aurontx.com

Highlights

Focus Areas

Biotechnology

Health Care

Therapeutics

Recent Investors

A

Financials

$60.8M

Total Raised

2

Funding rounds

9

Investors

Team

Upgrade to view the team

See the team members at Auron Therapeutics.